Benitez, J., Finlay, D., Ma, J., Koga, T., Vuori, K., & Furnari, F. (2018). CADD-21. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS. Neuro Oncol.

Benitez, Jorge, Darren Finlay, Jianhui Ma, Tomoyuki Koga, Kristiina Vuori, and Frank Furnari. "CADD-21. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS." Neuro Oncol 2018.

Benitez, Jorge, et al. "CADD-21. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS." Neuro Oncol 2018.